🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
The purpose of this study was to compare relapse-free survival between part...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-08-16
Trial ID
NCT02997202
Treatments Being Tested
The study population consisted of FLT3-ITD-mutated AML patients who were FL...
Status
Recruiting
Location
the First Affiliated Hosptital of Soochow University
Start Date
2026-05-01
Trial ID
NCT07463651
Treatments Being Tested
The purpose of the study was to provide access to continued treatment for t...
Status
Completed
Location
Site US10005
Start Date
2016-05-03
Trial ID
NCT02561455
Treatments Being Tested
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Active Not Recruiting
Location
Site CN103
Start Date
2017-10-25
Trial ID
NCT03182244
Treatments Being Tested
The purpose of this study was to compare relapse-free survival (RFS) betwee...
Status
Completed
Location
Site US10017
Start Date
2017-01-10
Trial ID
NCT02927262
Treatments Being Tested
The purpose of this study is to evaluate the dose-limiting toxicities (DLT)...
Status
Withdrawn
Location
University of Kentucky
Start Date
2023-03
Trial ID
NCT05330377
Treatments Being Tested
The objective of this study was to assess the safety and tolerability, incl...
Status
Completed
Location
Site US10021
Start Date
2013-10-09
Trial ID
NCT02014558
Treatments Being Tested
The primary objective of this study is to evaluate the safety of lanrapleni...
Status
Terminated
Location
University of California Los Angeles (UCLA)
Start Date
2022-08-05
Trial ID
NCT05028751
Treatments Being Tested